Imbruvica Awarded Prix Galien 2015 Best Pharmaceutical Agent

AbbVie has announced that Imbruvica was awarded the prestigious Prix Galien 2015 Award for Best Pharmaceutical Agent.

PRESS RELEASE

NORTH CHICAGO, Ill.

,

Oct. 28, 2015

/PRNewswire/ -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, announced today that IMBRUVICA® (ibrutinib) was awarded the prestigious Prix Galien 2015 Award for Best Pharmaceutical Agent. IMBRUVICA won this distinction out of 24 category nominees, all of which were deemed innovative in the field of medicine and were approved by the U.S. Food and Drug Administration (FDA) within the past five years. IMBRUVICA is jointly developed and commercialized by Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc.

"We are honored that IMBRUVICA, a first-in-class, oral therapy has been recognized by the Prix Galien

USA

Committee for the role it continues to play in treating patients with certain blood cancers," said Erik von Borcke, President of Pharmacyclics. "Our goal is to continue developing clinically meaningful, scientifically sound therapies that offer healthcare professionals and their patients the opportunity at the best possible outcome, allowing them to resume as normal a life as possible."

Considered to be the biomedical industry's highest accolade, the Prix Galien Award recognizes outstanding achievement in the development of new therapies. The Prix Galien was created in

France

in 1970 in honor of Galen, the father of medical science and modern pharmacology. Worldwide, the Prix Galien Award is generally regarded as the equivalent of the Nobel Prize in biopharmaceutical and medical technology research.

Related Videos
Credit: wladimir1804 - stock.adobe.com
Women buying contraceptive pills in the pharmacy | Image credit: Antonioguillem - stock.adobe.com
Healthcare technology | Image credit: ipopba | stock.adobe.com
Gastroenterologist using digital x-ray of human intestine holographic scan projection 3D rendering | Image Credit: sdecoret - stock.adobe.com
Supreme Court | Image credit: steheap - stock.adobe.com
Pharmacists talking with a nurse | Image credit: Jacob Lund - stock.adobe.com
Healthcare technology | Image credit: ipopba | stock.adobe.com
Related Content
© 2023 MJH Life Sciences

All rights reserved.